Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Liabilities and Shareholders Equity: 2015-2025

Historic Liabilities and Shareholders Equity for MediWound (MDWD) over the last 9 years, with Sep 2025 value amounting to $94.4 million.

  • MediWound's Liabilities and Shareholders Equity rose 26.35% to $94.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $303.9 million, marking a year-over-year increase of 16.51%. This contributed to the annual value of $73.5 million for FY2024, which is 10.59% up from last year.
  • According to the latest figures from Q3 2025, MediWound's Liabilities and Shareholders Equity is $94.4 million, which was up 40.93% from $67.0 million recorded in Q2 2025.
  • MediWound's 5-year Liabilities and Shareholders Equity high stood at $94.4 million for Q3 2025, and its period low was $19.7 million during Q4 2021.
  • In the last 3 years, MediWound's Liabilities and Shareholders Equity had a median value of $67.0 million in 2023 and averaged $69.5 million.
  • As far as peak fluctuations go, MediWound's Liabilities and Shareholders Equity plummeted by 36.45% in 2021, and later skyrocketed by 204.97% in 2023.
  • Quarterly analysis of 5 years shows MediWound's Liabilities and Shareholders Equity stood at $19.7 million in 2021, then soared by 153.32% to $50.0 million in 2022, then surged by 32.88% to $66.5 million in 2023, then climbed by 10.59% to $73.5 million in 2024, then rose by 26.35% to $94.4 million in 2025.
  • Its last three reported values are $94.4 million in Q3 2025, $67.0 million for Q2 2025, and $69.0 million during Q1 2025.